The impact of allylamine-bile acid combinations on cell delivery microcapsules in diabetes

References

• Armin Mooranian RN, Al-Salami H. Viability and topographical analysis of microencapsulated β-cells exposed to a biotransformed tertiary bile acid: An ex vivo study. Int J Nano Biomater, 2016 (in press).
   Google Scholar
• Cantley J, Grey S, Maxwell P, Withers D. The hypoxia response pathway and β‐cell function. Diabetes Obes Metab, 2010;12:159–67.
   PubMed Web of Science ®Google Scholar
• Choi SE, Choi KM, Yoon IH, Shin JY, Kim JS, Park WY, Han DJ, Kim SC, Ahn C, Kim JY. IL-6 protects pancreatic islet beta cells from pro-inflammatory cytokines-induced cell death and functional impairment in vitro and in vivo. Transpl Immunol, 2004;13:43–53.
   PubMed Web of Science ®Google Scholar
• De Groot M, Schuurs TA, Van Schilfgaarde R. Causes of limited survival of microencapsulated pancreatic islet grafts. J Surg Res, 2004;121:141–50.
   PubMed Web of Science ®Google Scholar
• De Vos P, De Haan BJ, Kamps JA, Faas MM, Kitano T. Zeta-potentials of alginate-PLL capsules: A predictive measure for biocompatibility? J Biomed Mater Res a, 2007;80:813–19.
   PubMed Web of Science ®Google Scholar
• De Vos P, Faas MM, Strand B, Calafiore R. Alginate-based microcapsules for immunoisolation of pancreatic islets. Biomaterials, 2006;27:5603–17.
   PubMed Web of Science ®Google Scholar
• De Vos P, Hamel A, Tatarkiewicz K. Considerations for successful transplantation of encapsulated pancreatic islets. Diabetologia, 2002;45:159–73.
   PubMed Web of Science ®Google Scholar
• De Vos P, Lazarjani HA, Poncelet D, Faas MM. Polymers in cell encapsulation from an enveloped cell perspective. Adv Drug Deliv Rev, 2014;67?68:15–34.
   PubMed Web of Science ®Google Scholar
• Engin F, Yermalovich A, Nguyen T, Hummasti S, Fu W, Eizirik DL, Mathis D, Hotamisligil GS. Restoration of the unfolded protein response in pancreatic β cells protects mice against type 1 diabetes. Sci Transl Med, 2013;5:211ra156.
   PubMed Web of Science ®Google Scholar
• Ichii H, Ricordi C. Current status of islet cell transplantation. J Hepatobiliary Pancreat Surg, 2009;16:101–12.
   PubMedGoogle Scholar
• Labhasetwar VD, Dorle AK. A study on the zeta potential of microcapsules during ageing. J Microencapsul, 1991;8:83–5.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Al-Salami H. The effects of Ionic Gelation-Vibrational Jet Flow technique in fabrication of microcapsules incorporating beta-cell: Applications in Type-1 Diabetes. Curr Diabetes Rev, 2015a. (in press).
   PubMedGoogle Scholar
• Mooranian A, Negrulj R, Al-Salami H. The incorporation of water-soluble gel matrix into bile acid-based microcapsules for the delivery of viable β-cells of the pancreas, in diabetes treatment: Biocompatibility and functionality studies. Drug Deliv Transl Res, 2016a;6:17–23.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Al-Salami H. Alginate–deoxycholic acid interaction and its impact on pancreatic Β-cells and insulin secretion and potential treatment of type 1 diabetes. J Pharm Innov, 2016b;11:156–61.
   Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Al-Salami H. Flow vibration-doubled concentric system coupled with low ratio amine to produce bile acid-macrocapsules of β-cells. Ther Deliv, 2016c;7:171–8.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Al-Salami H. The influence of stabilised deconjugated ursodeoxycholic acid on polymer-hydrogel system of transplantable NIT-1 cells. Pharm Res, 2016d;33:1182–90.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Al-Salami H. Primary bile acid chenodeoxycholic acid-based microcapsules to examine β-cell survival and the inflammatory response. BioNanoScience, 2016e;6:103–9.
   Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Al-Salami H, Morahan G, Jamieson E. Designing anti-diabetic beta-cells microcapsules using polystyrenic sulphonate, polyallylamine, and a tertiary bile acid: Morphology, bioenergetics, and cytokine analysis. Biotechnol Prog, 2016f;32:501–9.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Al-Sallami HS, Fang Z, Mikov M, Golocorbin-Kon S, Fakhoury M, Aruso F, Al-Salami H. Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment. J Microencapsul, 2015b;32:151–6.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Arfuso F, Al-Salami H. Characterisation of a novel bile acid-based delivery platform for microencapsulated pancreatic beta-cells. Artif Cells Nanomed Biotechnol, 2016g;44:194–200.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Arfuso F, Al-Salami H. The effect of a tertiary bile acid, taurocholic acid, on the morphology and physical characteristics of microencapsulated probucol: Potential applications in diabetes: A characterisation study. Drug Deliv Transl Res, 2015c;5:511–22.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Arfuso F, Al-Salami H. Multicompartmental, multilayered probucol microcapsules for diabetes mellitus: Formulation characterisation and effects on production of insulin and inflammation in a pancreatic beta-cell line. Artif Cells Nanomed Biotechnol, 2015d (in press).
   Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Chen-Tan N, Al-Sallami HS, Fang Z, Mukkur T, Mikov M, Golocorbin-Kon S, Fakhoury M, Watts GF, et al. Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol. Drug Des Dev Ther, 2014a;8:1221–30.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Chen-Tan N, Fakhoury M, Arfuso F, Jones F, Al-Salami H. Advanced bile acid-based multi-compartmental microencapsulated pancreatic beta-cells integrating a polyelectrolyte-bile acid formulation, for diabetes treatment. Artif Cells Nanomed Biotechnol, 2016h;44:588–95.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Chen-Tan N, Fakhoury M, Jones F, Arfuso F, Al-Salami H. Novel multicompartmental bile acid-based microcapsules for pancreatic beta-cell transplantation. Transplantation, 2015e;99:S151–2.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Chen-Tan N, Fakhoury M, Jones F, Arfuso F, Al-Salami H. Novel multicompartmental bile acid-based microcapsules for pancreatic beta-cell transplantation. Xenotransplantation, 2015f;22:S93–4.
   Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Mathavan S, Martinez J, Sciarretta J, Chen-Tan N, Mukkur T, Mikov M, Lalic-Popovic M, Stojančević M. Stability and release kinetics of an advanced gliclazide-cholic acid formulation: The use of artificial-cell microencapsulation in slow release targeted oral delivery of antidiabetics. J Pharm Innov, 2014b;9:150–7.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Mikov M, Golocorbin-Kon S, Arfuso F, Al-Salami H. Novel chenodeoxycholic acid–sodium alginate matrix in the microencapsulation of the potential antidiabetic drug, probucol. An in vitro study. J Microencapsul, 2015g;32:589–97.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Morahan G, Jamieson E, Al-Salami H. Designing anti-diabetic beta-cells microcapsules using polystyrenic sulphonate, polyallylamine and a tertiary bile acid: Morphology, bioenergetics and cytokine analysis. Biotechnol Prog, 2016i;32:501–9.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulja R, Chen-Tanb N, Al-Sallamic HS, Fangd Z, Mikov M, Golocorbin-Kong S, Fakhouri M, Arfusoe F, Al-Salamia H. Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: A characterisation study. Drug Des Dev Ther, 2014c;8:1003–12.
   PubMed Web of Science ®Google Scholar
• Negrulj R, Mooranian A, Chen-Tan N, Al-Sallami HS, Mikov M, Golocorbin-Kon S, Fakhoury M, Watts GF, Arfuso F, Al-Salami H. Swelling, mechanical strength, and release properties of probucol microcapsules with and without a bile acid, and their potential oral delivery in diabetes. Artif Cells Nanomed Biotechnol, 2016;44:1290–7.
   PubMed Web of Science ®Google Scholar
• Robertson OH, Puck TT, Lemon HF, Loosli CG. The lethal effect of triethylene glycol vapor on air-borne bacteria and influenza virus. Science, 1943;97:142–4.
   PubMedGoogle Scholar
• Robertson RP. Islet transplantation as a treatment for diabetes – A work in progress. N Engl J Med, 2004;350:694–705.
   PubMed Web of Science ®Google Scholar
• Takka S, Cali AG. Bile salt-reinforced alginate–chitosan beads. Pharm Dev Technol, 2012;17:23–9.
   PubMed Web of Science ®Google Scholar
• Vaithilingam V, Tuch BE. Islet transplantation and encapsulation: An update on recent developments. Rev Diabet Stud, 2011;8:51–67.
   PubMedGoogle Scholar
• Weir GC. Islet encapsulation: Advances and obstacles. Diabetologia, 2013;56:1458–61.
   PubMed Web of Science ®Google Scholar